Market Closed -
Nyse
04:00:02 2024-05-15 pm EDT
5-day change
1st Jan Change
19.09
USD
-1.14%
-3.10%
+14.52%
Presentation Operator MessageOperator (Operator)Good day, and thank you for standing by. Welco...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Adaptimmune Therapeutics Enters Into $125 Million Term Loan Facility With Hercules Capital
May. 15
MT
X4 Pharmaceuticals Receives $125 Million Additional Capital; Shares Rise
May. 09
MT
Verona Pharma Signs Financing Agreements for Up to $650 Million
May. 09
MT
Transcript : Hercules Capital, Inc., Q1 2024 Earnings Call, May 02, 2024
May. 02
Hercules Capital, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
May. 02
CI
Hercules Capital Signs $35 Million Loan Facility to Fund Development of Tenosynovial Giant Cell Tumour Treatment
Apr. 30
MT
KARL STORZ SE & Co. KG entered into an agreement to acquire Asensus Surgical, Inc. for $100 million.
Apr. 02
CI
Bluebird bio to Restate Financial Statements; Shares Fall
Mar. 26
MT
JMP Securities Adjusts Hercules Capital Price Target to $19 From $18, Maintains Market Outperform Rating
Mar. 26
MT
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon
Mar. 18
MT
Sector Update: Health Care
Mar. 18
MT
Bluebird bio Secures $175 Million Term Loan Facility
Mar. 18
MT
Health Data Vision, Inc. announced that it has received $65 million in funding from Hercules Capital, Inc.
Feb. 25
CI
Piper Sandler Raises Price Target on Hercules Capital to $20 From $18.50, Maintains Overweight Rating
Feb. 16
MT
Hercules Capital Posts Increased Q4 Net, Total Investment Income
Feb. 15
MT
Transcript : Hercules Capital, Inc., Q4 2023 Earnings Call, Feb 15, 2024
Feb. 15
Hercules Capital, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
Feb. 15
CI
Hercules Capital, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Feb. 15
CI
Wheat Futures Fall as Russian Export Prices Sink -- Daily Grain Highlights
Feb. 15
DJ
Haveli Investments Software Fund I, L.P., a fund managed by Haveli Investment Management LLC entered into an Agreement and Plan of Merger to acquire ZeroFox Holdings, Inc. (NasdaqGM : ZFOX) from Monarch Alternative Capital LP and Others for approximately $150 million.
Feb. 05
CI
Wells Fargo Adjusts Price Target on Hercules Capital to $18 From $17, Maintains Overweight Rating
Jan. 29
MT
North American Morning Briefing : Central Bankers -2-
Jan. 17
DJ
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday as Traders Exercise Caution
Jan. 02
MT
Verona Pharma Secures $400 Million Debt Facility With Oxford Finance, Hercules Capital
Jan. 02
MT
UBS Initiates Coverage on Hercules Capital With Neutral Rating, $17 Price Target
Nov. 21
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Hercules Capital, Inc. is a specialty finance company. The Company is focused on providing financing solutions to venture capital-backed and institutional-backed companies in a variety of technology, life sciences and sustainable and renewable technology industries. It is structured as an internally managed, non-diversified, closed-end investment company. Its business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments in primarily Structured Debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology related industries at attractive yields. It invests in a range of companies active in the technology industry sub-sectors characterized by products or services that require advanced technologies, including, computer software and hardware, networking systems, semiconductors, semiconductor capital equipment, information technology infrastructure and others.
More about the company
Last Close Price
19.09
USD
Average target price
19.69
USD
Spread / Average Target
+3.17%
Consensus
1st Jan change
Capi.
+14.52% 3.05B +31.41% 2.06B +8.98% 1.51B -11.54% 1.2B +14.80% 756M +9.28% 666M +33.50% 570M -4.17% 503M +25.78% 466M +3.90% 309M
Venture Capital
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**
-40% Limited Time Offer : Our subscriptions help you unlock hidden opportunities.**#000000**/services/solutions/**#fff826**#ff3000**#ffffff**
BENEFIT NOW **0**linear-gradient(180deg, rgba(42,73,76,1) 0%, rgba(28,30,51,1) 53%);**linear-gradient(180deg, rgba(255, 248, 38,1) 0%, rgba(247, 239,1) 53%);**date_fin_hors_prolongation**49**on all our subscriptions**
#252525**/registration/member/**Blanc**1**7**To continue browsing, please register!**#ffffff50**14px**#33d251**